Better than expected job growth sent the market soaring to a sharply higher close with the Dow leaping 186 points to 20,071. Nasdaq climbed 30 points to 5,666.
On the upside
MYOS RENS Technology (Nasdaq: MYOS) announced that an institutional investor will purchase approximately $2.125 million of common stock through a registered direct offering.
Upbeat trial data from Amgen (Nasdaq: AMGN) for its PCSK9 lifted shares of The Medicines Company (Nasdaq: MDCO), which has a similar product in development, and Esperion Therapeutics (Nasdaq: ESPR).
Bristow Group (NYSE: BRS) reported a smaller than expected loss for the third quarter.
On the downside
Trading in Power Solutions International (Nasdaq: PSIX) was temporarily halted today.
Pulmatrix (Nasdaq: PULM) announced a registered direct offering with several institutional investors to purchase approximately $3.33 million worth of common stock.
Investors locked in profits on Benitec Biopharma (Nasdaq: BNTC).
In the broad market, advancing issues outpaced decliners by a margin of 7 to 2 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 index climbed 16 points to 2,297. Bitcoin rose $4 to $1,002.